In this 227th episode I welcome Dr. Christian Meyhoff to the show from Denmark where he is one of the world leaders on hyperoxia research. We discuss his recent VIXIE Trial as well as his A&A article looking at the VISION study data retrospectively. We also discuss why the data on hyperoxia is so mixed and what future studies should examine.
Our Sponsors:
* Check out BetterHelp and use my code betterhelp.com for a great deal: https://www.betterhelp.com
* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com
* Check out Factor and use my code factormeals.com/accrac50off for a great deal: https://www.factor75.com
* Check out Kiwi Biosciences and use my code icaneatagain.com/accrac for a great deal: https://www.kiwibiosciences.com
* Check out Quince and use my code quince.com/accrac for a great deal: https://www.quince.com
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
Fler avsnitt av Anesthesia and Critical Care Reviews and Commentary (ACCRAC) Podcast
Visa alla avsnitt av Anesthesia and Critical Care Reviews and Commentary (ACCRAC) PodcastAnesthesia and Critical Care Reviews and Commentary (ACCRAC) Podcast med Jed Wolpaw finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
